Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
24
PSTV
Plus Therapeutics
Last Price:
$1.09
Seasonality Move:
5.93%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
The current trend is relatively stagnant and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Sell |
20-day SMA: | 1.24 | Sell |
50-day SMA: | 1.29 | Sell |
200-day SMA: | 1.63 | Sell |
8-day EMA: | 1.13 | Sell |
20-day EMA: | 1.21 | Sell |
50-day EMA: | 1.29 | Sell |
200-day EMA: | 1.64 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 39.12 | Sell |
Chaikin Money Flow: | 34849 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.12 - 1.34) | Sell |
Bollinger Bands (100): | (1.23 - 1.53) | Sell |
Plus Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 1.09 while PSTV 8-day simple moving average is 1.16, which is a Sell signal.
-
The stock price of PSTV is 1.09 while Plus Therapeutics 20-day SMA is 1.24, which makes it a Sell.
-
Plus Therapeutics 50-day simple moving average is 1.29 while PSTV share price is 1.09, making it a Sell technically.
-
PSTV stock price is 1.09 and Plus Therapeutics 200-day simple moving average is 1.63, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
24
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a SellThe current Plus Therapeutics [PSTV] share price is $1.09. The Score for PSTV is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
6.4M
Price in USD:
1.09
Share Volume:
49K
Plus Therapeutics 52-Week Range
52-Week High:
2.67
52-Week Low:
0.93
Sell
24
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?The Plus Therapeutics stock price is 1.09 USD today.
-
Will PSTV stock go up or go down?Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Plus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
-
Plus Therapeutics share price is 1.09 while PSTV 8-day exponential moving average is 1.13, which is a Sell signal.
-
The stock price of PSTV is 1.09 while Plus Therapeutics 20-day EMA is 1.21, which makes it a Sell.
-
Plus Therapeutics 50-day exponential moving average is 1.29 while PSTV share price is 1.09, making it a Sell technically.
-
PSTV stock price is 1.09 and Plus Therapeutics 200-day simple moving average is 1.64, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
-
PSTV Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Plus Therapeutics is a Sell
-
Plus Therapeutics Relative Strength Index (RSI) is 39.12, which suggest Plus Therapeutics is oversold
-
The Bollinger Bands (25) for Plus Therapeutics is (1.12 - 1.34), which suggest Plus Therapeutics is a Sell
-
The Bollinger Bands (100) for Plus Therapeutics is (1.23 - 1.53), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.